gamfluvac
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2018 (NCT03651544)
Timeline
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04034290 | Phase 2 | Sep 30, 2019 | Government of Russia, Russian Military |
| NCT03651544 | Phase 1 | Oct 1, 2018 | Government of Russia, Russian Military |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Russia | Government | 2 | 2 | 2 | 2018 |
| Russian Military | Government | 2 | 0 | 2 | 2018 |
2 organizations
Page 1 / 1